These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19402218)

  • 1. Selective phosphodiesterase-3 inhibitor cilostazol ameliorates experimental autoimmune encephalomyelitis.
    Kureshiro J; Miyamoto K; Tanaka N; Kusunoki S
    Neuroreport; 2009 May; 20(7):718-22. PubMed ID: 19402218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of encephalitogenic T-cell responses by cilostazol is associated with upregulation of regulatory T cells.
    Wang S; Yan C; Xu H; Zhao X; Han Y
    Neuroreport; 2010 Jun; 21(9):629-35. PubMed ID: 20473232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS.
    Sinha S; Subramanian S; Proctor TM; Kaler LJ; Grafe M; Dahan R; Huan J; Vandenbark AA; Burrows GG; Offner H
    J Neurosci; 2007 Nov; 27(46):12531-9. PubMed ID: 18003831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol extract of Glycyrrhizae Radix modulates the responses of antigen-specific splenocytes in experimental autoimmune encephalomyelitis.
    Yang EJ; Song IS; Song KS
    Phytomedicine; 2019 Feb; 54():56-65. PubMed ID: 30668383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical role of LFA-1 in the development of Th17 cells and induction of experimental autoimmune encephalomyelytis.
    Wang Y; Kai H; Chang F; Shibata K; Tahara-Hanaoka S; Honda S; Shibuya A; Shibuya K
    Biochem Biophys Res Commun; 2007 Feb; 353(4):857-62. PubMed ID: 17207459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
    Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
    Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.
    Kato H; Ito A; Kawanokuchi J; Jin S; Mizuno T; Ojika K; Ueda R; Suzumura A
    Mult Scler; 2004 Dec; 10(6):651-9. PubMed ID: 15584490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Zhu D; Liu M; Yang Y; Ma L; Jiang Y; Zhou L; Huang Q; Pi R; Chen X
    J Neurosci Res; 2014 Sep; 92(9):1217-26. PubMed ID: 24798871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen-related cell adhesion molecule 1 modulates experimental autoimmune encephalomyelitis via an iNKT cell-dependent mechanism.
    Fujita M; Otsuka T; Mizuno M; Tomi C; Yamamura T; Miyake S
    Am J Pathol; 2009 Sep; 175(3):1116-23. PubMed ID: 19700760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stat4 isoforms differentially regulate inflammation and demyelination in experimental allergic encephalomyelitis.
    Mo C; Chearwae W; O'Malley JT; Adams SM; Kanakasabai S; Walline CC; Stritesky GL; Good SR; Perumal NB; Kaplan MH; Bright JJ
    J Immunol; 2008 Oct; 181(8):5681-90. PubMed ID: 18832727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.
    Liu L; Huang D; Matsui M; He TT; Hu T; Demartino J; Lu B; Gerard C; Ransohoff RM
    J Immunol; 2006 Apr; 176(7):4399-409. PubMed ID: 16547278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary investigation of phoshodiesterase 7 inhibitor VP3.15 as therapeutic agent for the treatment of experimental autoimmune encephalomyelitis mice.
    Martín-Álvarez R; Paúl-Fernández N; Palomo V; Gil C; Martínez A; Mengod G
    J Chem Neuroanat; 2017 Mar; 80():27-36. PubMed ID: 28007551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
    Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
    J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of dasatinib in mouse model of multiple sclerosis.
    Azizi G; Goudarzvand M; Afraei S; Sedaghat R; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):287-94. PubMed ID: 25975582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
    Imler TJ; Petro TM
    Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvacrol ameliorates experimental autoimmune encephalomyelitis through modulating pro- and anti-inflammatory cytokines.
    Mahmoodi M; Amiri H; Ayoobi F; Rahmani M; Taghipour Z; Ghavamabadi RT; Jafarzadeh A; Sankian M
    Life Sci; 2019 Feb; 219():257-263. PubMed ID: 30472298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis.
    Chen SJ; Huang SH; Chen JW; Wang KC; Yang YR; Liu PF; Lin GJ; Sytwu HK
    Int Immunopharmacol; 2016 Feb; 31():169-77. PubMed ID: 26735612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice.
    Oliver AR; Lyon GM; Ruddle NH
    J Immunol; 2003 Jul; 171(1):462-8. PubMed ID: 12817031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.